Elisabeth Lukasser-Vogl

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

Andreas Gruber, Cornelia Speth, Elisabeth Lukasser-Vogl et al. · Immunopharmacology · 1999 · 72 citations

Protease Inhibitor, Human Retrovirus, Pathogenesis +9

Human Immunodeficiency Virus Type 1 gp160 and gp41 Binding to Candida albicans Selectively Enhances Candidal Virulence In Vitro

Andreas Gruber, Elisabeth Lukasser-Vogl, Margarete Borg‐von Zepelin et al. · The Journal of Infectious Diseases · 1998 · 61 citations · Full text

Hiv-1 Gp160, Gp41 Binding, Immunology +16

Human Immunodeficiency Virus Type 1 gp41 Binds to<i>Candida albicans</i>via Complement C3‐like Regions

Reinhard Würzner, Andreas Gruber, Heribert Stoiber et al. · The Journal of Infectious Diseases · 1997 · 22 citations · Full text

Microbial Pathogens, Complement C3‐like Regions, Immunology +19

Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes

Elisabeth Lukasser-Vogl, Andreas Gruber, Cornelia Lass‐Flörl et al. · FEMS Immunology & Medical Microbiology · 2000 · 14 citations · Full text

Protein Secretion, Microbial Pathogens, Immunology +21